# American Red Cross Blood Services – FDA Inspection, Jan 7, 2020

Source: https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/079b036d-5ec6-4598-b77b-323174204b70
Source feed: FDA_Inspections

> FDA inspection 1114962 of American Red Cross Blood Services, January 07, 2020. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1114962
- Company Name: American Red Cross Blood Services
- Inspection Date: 2020-01-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1324182 - 2026-06-05
- FDA Inspection 1062469 - 2018-07-19
- FDA Inspection 944773 - 2015-09-17
- [FDA Inspection 831874 - 2013-05-03](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/9c32c208-1a53-43b9-af8e-7587611412c8)
- FDA Inspection 783488 - 2012-05-04

Company: https://www.keypedia.com/companies/american-red-cross-blood-services/e071de9d-54a8-4cca-add1-8754e02b6952

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d